DidanosineDidanosine
MedChemExpress (MCE)
HY-B0249
69655-05-6
2',3'-Dideoxyinosine
ddI
99.45%
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Room temperature in continental US
may vary elsewhere.
Didanosine (2',3'-Dideoxyinosine
ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV.
Didanosine is converted by cellular enzymes to the active antiviral metabolite dideoxyadenosine triphosphate (dd-ATP) and the intracellular half life of dd-ATP varies from 8-24 hours[1]. Didanosine shows antiretroviral activity with IC50 value of 0.24-0.6 mg/L for HIV infection[3]. Didanosine (5, 10, 50, 100 ug/ml
24, 48 h) shows no significant inhibition of cell proliferation in IEC-6 cells[2].
Didanosine (100, 150 mg/kg
p.o.
daily for 7 days) decreases the length of duodenal and in jejunal villus in mouse[2].
| | | |
| | | | | |
[1]. Munir N.Nassar, et al. Analytical profiles of drug substances and excipients. Journals & Books, 1993, 185-227.
[2]. Braga Neto MB, et al. Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice. BMC Gastroenterol. 2010 Aug 11
10:90. [Content Brief]
[3]. Caroline M. Perry, et al. Didanosine. Drugs, 1999, 58, 1099-1135.